HCW Biologics Inc. (HCWB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$13.39M | +5.9% |
| 2024 | -$14.23M | +36.8% |
| 2023 | -$22.51M | -116.8% |
| 2022 | -$10.39M | +5.4% |
| 2021 | -$10.98M | -5.2% |
| 2020 | -$10.43M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$13.39M | +5.9% |
| 2024 | -$14.23M | +36.8% |
| 2023 | -$22.51M | -116.8% |
| 2022 | -$10.39M | +5.4% |
| 2021 | -$10.98M | -5.2% |
| 2020 | -$10.43M | — |